REVIEW
Temozolomide in aggressive pituitary adenomas and carcinomas
Leon D. OrtizI, Luis V. SyroII,
, Bernd W. Scheithauer (in memoriam)III, Fabio RotondoIV, Humberto UribeV, Camilo E. FadulVI, Eva HorvathIV, Kalman KovacsIV
Corresponding author
I Instituto de Cancerologia, Clinica Las Americas, Division of Neuro-oncology, Medellin, Colombia.
II Hospital Pablo Tobon Uribe and Clinica Medellin, Department of Neurosurgery, Medellin, Colombia.
III Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, Minnesota, USA.
IV University of Toronto, St Michael's Hospital, Department of Laboratory Medicine, Toronto, Ontario, Canada.
V Clinica SOMA, Department of Neurosurgery, Medellin, Colombia.
VI Dartmouth Hitchcock Medical Center, Department of Medicine (Section of Hematology/Oncology) and Neurology, Lebanon, New Hampshire, USA.
Read
388
Timeswas read the article
216
Total PDF
172
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 July | 8 | 11 | 19 |
| 2024 June | 15 | 6 | 21 |
| 2024 May | 15 | 14 | 29 |
| 2024 April | 14 | 21 | 35 |
| 2024 March | 17 | 12 | 29 |
| 2024 February | 18 | 14 | 32 |
| 2024 January | 8 | 10 | 18 |
| 2023 December | 8 | 16 | 24 |
| 2023 November | 12 | 16 | 28 |
| 2023 October | 13 | 34 | 47 |
| 2023 September | 13 | 24 | 37 |
| 2023 August | 7 | 7 | 14 |
| 2023 July | 8 | 20 | 28 |
| 2023 June | 8 | 4 | 12 |
| 2023 May | 1 | 1 | 2 |
| 2023 April | 1 | 3 | 4 |
| 2023 March | 1 | 1 | 2 |
| 2023 February | 1 | 0 | 1 |
| 2023 January | 3 | 1 | 4 |
| 2022 December | 1 | 1 | 2 |
Show all